• English
  • Français
Bladder Cancer CanadaBladder Cancer CanadaBladder Cancer CanadaBladder Cancer Canada
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate

Home » Bladder Cancer Information » Staging & Grading Bladder Cancer

Types of Bladder Cancer Tumours, Stages & Grades

Bladder cancer presents differently in every patient and determining the type and shape of the tumour will determine the treatment strategy. After the tumour is identified, doctors will then assign a type, shape, stage and grade to decide the course of action and the treatment options.

Types of Bladder Cancer Tumours

Your cancer’s cell type, also called histological type, refers to what the cell structure looks like under the microscope and how the cells are arranged.

Bladder cancer includes many histological types:

  • Transitional cell carcinoma is the most common bladder cancer type and accounts for about 90% of bladder cancers.
  • Squamous cell carcinoma is cancer that begins in the thin, flat cells lining the inside of the bladder.
  • Adenocarcinoma is cancer that begins in glandular cells that are found in the lining of the bladder. Glandular cells in the bladder make mucus and other substances.
  • Small cell carcinoma starts in nerve-like cells called neuroendocrine cells. Less than 1% of bladder cancers are small cell carcinomas which includes neuroendocrine, micropapillary and mixed-pattern subtypes.
  • Sarcomatoid/plasmacytoid is an extremely rare aggressive tumour variant comprising about 0.3% of all primary bladder cancer.

Shapes of Bladder Cancer Tumours

Some types of bladder cancer tumours are classified based on their shape. The shape of your tumour can indicate how serious and aggressive the cancer may be.

  • Papillary tumours have long, finger-like projections that stretch out from the bladder wall toward your bladder’s interior.
  • Sessile tumours lie flat and are superficial tumours that may grow deeper into the bladder wall.
  • Carcinoma in situ (CIS) or a “flat tumour” is only found on or near the surface of the bladder. The doctor may also call it non-muscle invasive bladder cancer, superficial bladder cancer, or non-invasive flat carcinoma. This type of bladder cancer often comes back after treatment, usually as another non-invasive cancer in the bladder.

Staging & Grading of Bladder Cancer Tumours

Laboratory analysis of the material taken out during a Transurethral Resection of Bladder Tumour (TURBT) is used to determine the stage and grade of the cancer.

The urologist typically sends a sample of the cancer tissue to a pathologist, a doctor who specializes in examining tissue. Upon review of the subsequent pathology report, the doctor will determine an optimal treatment plan.

Upon diagnosis of bladder cancer, it is imperative for the doctor to determine the stage or extent of the disease. Staging involves assessing whether the cancer has penetrated the bladder wall and if the disease has metastasized or spread, and if so, to which areas of the body.

Grade, on the other hand, pertains to the appearance of cancer cells and their rate of multiplication. A higher grade indicates greater cellular irregularity and proliferation. Understanding the grade aids the doctor in predicting the pace at which the bladder cancer will progress and spread.

What Bladder Cancer Stages & Grades Mean

Staging and grading bladder cancer – Bladder Cancer Canada

Tis – Carcinoma in situ (flat tumour), sometimes called Cis.

Ta – Non-invasive papillary carcinoma.

T1 – The tumour is in the first layer of the bladder lining, but not the surrounding muscle.

T2 – The tumour has grown into the muscle. In stage T2a, the tumour is in the inner half of the muscle layer and in stage T2b, the outer half.

T3 – The tumour has spread to the fatty layer around the bladder muscle. T3a describes a microscopic tumour and T3b a large tumour that can be seen or felt.

T4 – The tumour has spread to organs outside the bladder (T4a) or to the wall of the abdomen or pelvis (T4b).

Staging Bladder Cancer

Sometimes it may be difficult for your medical team to know the true extent of your tumour without surgery because there may be a difference between “clinical staging” and “pathological staging.”

The resection of the tumour or TURBT is part of the clinical staging process, which is done before treatment. Clinical staging also includes a physical exam, imaging tests (such as a CT scan), laboratory tests (such as blood tests), and biopsies.

Cancer can be further staged by examining the material removed during a radical cystectomy or bladder removal. This process is called pathologic staging. Complete staging combines the results of the clinical staging with the surgical results. Should you decide not to have your bladder removed, the medical team will determine the stage through the initial resection or clinical staging process.

Grading Bladder Cancer

The pathology report that follows the TURBT will generally show whether the tumour is “high grade” or “low grade.” A diagnosis of muscle-invasive bladder cancer may be based on the finding of high-grade tumours. If possible, keep a copy of the pathology report, which will tell you the stage and grade of your tumour.

  • Low-grade tumours grow slowly, and rarely invade other tissues or spread to other parts of the body.
  • High-grade tumours are more likely to recur and may become invasive. These tumours contain cells that grow abnormally and can invade other tissues and spread to other parts of the body.

Illustration Credit: Zuzanna Gorski, Mypathologyreport.ca

There are many types and shapes of bladder cancer tumours that are identified after the tumours are removed for laboratory analysis. Determining the type and shape of a tumour helps doctors to know how to treat the bladder cancer.

To read more about the staging and grading of bladder cancer along with other trending topics, visit our forums hosted by bladder cancer survivors and talk to people who have been there!

YOU ARE NOT ALONE.
WE'RE HERE FOR YOU!

Bladder Cancer Canada

4936 Yonge Street, Suite 1000, Toronto, ON M2N 6S3
Phone: 1-866-674-8889
Email & Media Contact: info@bladdercancercanada.org

Privacy Policy | Donor Bill of Rights

Charitable Reg No. 83612 6060 RR0001

© Bladder Cancer Canada.

SUBSCRIBE TO OUR NEWSLETTER
SEND US A MESSAGE
  • Bladder Cancer
    • See Red?
    • What is Bladder Cancer?
    • Statistics and Risk Factors
    • Symptoms and Diagnosis
    • Staging and Grading
    • Types of Bladder Cancer
      • Non-Muscle Invasive Bladder Cancer
      • Muscle Invasive Bladder Cancer
      • Metastatic Bladder Cancer
      • Upper Tract Urothelial Carcinoma
    • Treatment Options
      • TURBT
      • BCG
      • Chemotherapy and Radiation
      • Bladder Removal
      • Immunotherapy
      • Bladder Preservation Options
      • Palliative Care
      • Clinical Trials
      • Advanced Bladder Cancer Treatment
    • Research and Studies
  • Patients
    • Get Support
      • Support Groups
      • One2One Peer Support
      • Online Discussion Forum
      • Contact Us by Phone or Email
    • Navigating Your Diagnosis
      • Newly Diagnosed?
      • Coping With Emotions
      • Health and Wellness Resources
      • Clinical Trials
    • Educational Resources
      • Guidebooks
      • Webinars and Videos
      • Podcast
      • Newsletter
      • Glossary
    • Upcoming Events
    • News and Stories
    • Links and Other Resources
  • Get Involved
    • Donate
    • Fundraise
    • Volunteer
    • Share Your Story
    • Patient Study Recruitment
    • Patient Self-Advocacy
    • Bladder Cancer Awareness Month
    • Your Impact
  • Health Care Practitioners
    • Doctor Resources
    • BCC Research Grant Applications
    • BCC Research Grant Recipients
    • CBCIS
    • CBCRN
    • Medical Advisory Board
  • About Us
    • Who We Are
    • Board of Directors
    • Staff
    • Medical Advisory Board
    • Sponsors and Partners
    • Financial Statements and Annual Reports
    • Newsletter
    • Contact Us
  • Walk With Us
  • Donate
Bladder Cancer Canada